GWP42003-P
GWEP18060
Approved small_molecule terminated
Quick answer
GWP42003-P for Lennox-Gastaut Syndrome is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Lennox-Gastaut Syndrome
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated